MoneyWorks4Me

Alkem Laboratories informs about press release

16 Sep 2026 Evaluate
Alkem Laboratories has informed that the Company today announced the launch of NeuCeno (cenobamate), anti-seizure medication (ASM) for the treatment of partialonset seizures in adult patients. A press release in this regard is enclosed.

The above information is a part of company’s filings submitted to BSE.
Peers
Company Name CMP
Sun Pharma. Inds. 1846.90
Dr. Reddys Labs. 1212.85
Cipla 1369.60
Lupin 2122.95
Zydus Lifesciences 1172.50
View more..